NASDAQ · Medical - Devices

MASS (MASS) Stock

$10.04 -2.81% NASDAQ: MASS Healthcare

Valuation

MetricValue
Price$10.04
Market Cap$411.91M
P/E Ratio-10.80
P/B Ratio2.99
P/S Ratio6.77
EPS (TTM)$0.54
52-Week High$11.25
52-Week Low$5.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.50%
ROA-17.46%
ROCE-18.90%
Gross Margin-42.86%
Operating Margin-42.86%
Net Margin-56.68%
Debt/Equity0.03
Current Ratio4.26

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$47.0M$50.0M$60.0M$56.0M
Operating Profit$-22.0M$-35.0M$-43.0M$-77.0M$-24.0M
Net Profit$-22.0M$-34.0M$-36.0M$-72.0M$-37.0M
EPS$-0.79$-1.07$-1.13$-2.12$-0.94
Op Margin-52.3%-75.5%-85.1%-128.7%-43.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$261.0M$243.0M$203.0M$159.0M$190.0M
Total Liabilities$46.0M$52.0M$37.0M$45.0M$46.0M
Cash$224.0M$188.0M$121.0M$44.0M$113.0M
Borrowings$21.0M$20.0M$6.0M$7.0M$17.0M

Latest News

Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031 GlobeNewswire · Jul 6, 2026 908 Devices (MASS) Upgraded to Buy: Here's Why Zacks · Jun 4, 2026 908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire · Jun 2, 2026 908 Devices MASS Q1 2026 Earnings Transcript Motley Fool · May 7, 2026 908 Devices Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-21.0M$-25.0M$-30.0M$-24.0M
Investing Cash Flow$-1.0M$-18.0M$-28.0M$-47.0M$50.0M
Financing Cash Flow$94.0M$0$-2.0M$-2.0M$-2.0M
Net Cash Flow$65.0M$-36.0M$-67.0M$-77.0M$26.0M
Free Cash Flow$-30.0M$-23.0M$-27.0M$-31.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-11.87
FCF Yield0.12%
Quick Ratio2.38
Interest Coverage0.00
Return 1Y-3.00%
Return 3Y-5.83%
Return 5Y-74.35%

Ownership

Insiders Held8.21%
Institutions Held82.81%
Institutions Float Held90.21%
Institutional HolderSharesReport Date
First Light Asset Management, LLC6,072,5632026-03-31
AWM Investment Company, Inc.5,199,9242026-03-31
ARK Investment Management, LLC1,946,6852026-03-31
Blackrock Inc.1,767,3162026-03-31
Needham Investment Management, L.L.C.1,240,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRS $5.95 -3.72% -10.35 $831.00M 0.00%
CAPR $9.28 -6.17% -4.01 $533.70M 0.00%
CERS $2.57 -1.15% -34.25 $517.92M 0.00%
CVRX $3.01 -1.95% -2.98 $79.87M 0.00%
NNOX $0.71 -6.69% -0.63 $49.60M 0.00%

About MASS

MASS is led by CEO Kevin J. Knopp, publicly traded since 2020.

MASS stock trades at $10.04 with a market capitalization of $411.91M. The stock is valued at a price-to-earnings (P/E) ratio of -10.80, price-to-book of 2.99, price-to-sales of 6.77. Over the past 52 weeks the stock has ranged between $5.03 and $11.25, and currently trades 10.7% below its 52-week high.

On profitability, MASS generates a return on equity (ROE) of -25.50%, return on capital employed of -18.90%, an operating margin of -42.86%, a net profit margin of -56.68%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.50 -0.05% JNJ Drug Manufacturers - General $278.43 +1.17% ABBV Drug Manufacturers - General $260.30 -0.54% MRK Drug Manufacturers - General $152.34 +0.46% UNH Medical - Healthcare Plans $400.94 +0.32% NVS Drug Manufacturers - General $163.09 +0.39% AZN Drug Manufacturers - General $164.77 +1.94% AMGN Drug Manufacturers - General $444.12 +0.29% TMO Medical - Diagnostics & Research $618.43 +1.63% NVO Biotechnology $47.51 +1.58% ABT Medical - Devices $108.80 -1.51% GILD Drug Manufacturers - General $151.22 +1.08%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides